Business
CytoSorbents Completes its Mission 100,000 International Fundraising Campaign to Fight the Spread of COVID-19 for Global Humanitarian Organization, CARE
CytoSorbents to present a $100,000 check to CARE during the Opening Bell ceremony at NASDAQ today in New York City Times Square MONMOUTH JUNCTION, N.J., July
About this update from Cytosorbents Corporation
[{"type":"text","content":"CytoSorbents to present a $100,000 check to CARE during the Opening Bell ceremony at NASDAQ today in New York City Times Square\n\n\nMONMOUTH JUNCTION, N.J., July 30, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announces the successful completion of its MISSION 100,000 international fundraising campaign to fight the spread of COVID-19, raising $100,000 to benefit the global, not-for-profit humanitarian organization, CARE. The funds raised for CARE's Crisis Response Campaign enable the organization to provide various vaccination, education, sanitation, and disinfectant initiatives around the world to prevent the spread of COVID-19. CytoSorbents will present CARE its donation at the Opening Bell ceremony at NASDAQ later this morning.\n\n \n \n \n \n \n \n\n \nCytoSorbents successfully raises $100,000 for global humanitarian organization CARE to fight the spread of COVID-19The campaign commemorates a major Company milestone achieved last year of cumulatively shipping more than 100,000 CytoSorb® blood purification cartridges worldwide to treat deadly inflammation, such as seen in severe COVID-19 infection. That number has since grown to more than 131,000 cartridges, including those used to treat more than 6,000 COVID-19 patients across more than 30 countries, including the U.S.\nDr. Phillip Chan, Chief Executive Officer of CytoSorbents stated, \"On behalf of the Company, I would like to thank all of our friends, business partners, colleagues, employees, and shareholders for your generous donations, enabling us to match your support and fullfill our pledge to raise $100,000 to support CARE's COVID-19 Emergency Fund. With the rise in new COVID-19 cases caused by new highly contagious coronavirus variants, these funds will no doubt be put to good use. We are proud to support CARE and the global fight against the COVID-19 pandemic in communities here in the U.S., in Europe, and worldwide.\"\nMichelle Nunn, CARE USA President and CEO stated, \"As COVID has impacted the lives of hundreds of millions of marginalized people around the world, CARE's life-saving work has never been more important. We want to thank our partners at CytoSorbents for contributi...